These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of Ca(2+)-ionophore A23187 and calmodulin antagonists on regulatory mechanisms of glycolysis and cell viability of NIH-3T3 fibroblasts. Ashkenazy-Shahar M, Beitner R. Mol Genet Metab; 1999 Aug; 67(4):334-42. PubMed ID: 10444344 [Abstract] [Full Text] [Related]
4. The dual effects of Ca2+ on binding of the glycolytic enzymes, phosphofructokinase and aldolase, to muscle cytoskeleton. Chen-Zion M, Lilling G, Beitner R. Biochem Med Metab Biol; 1993 Apr; 49(2):173-81. PubMed ID: 8484959 [Abstract] [Full Text] [Related]
7. Serotonin decreases cytoskeletal and cytosolic glycolytic enzymes and the levels of ATP and glucose 1,6-bisphosphate in skin, which is prevented by the calmodulin antagonists thioridazine and clotrimazole. Ashkenazy-Shahar M, Beitner R. Biochem Mol Med; 1997 Apr; 60(2):187-93. PubMed ID: 9169102 [Abstract] [Full Text] [Related]
8. Platelet-derived growth factor (PDGF) rapidly stimulates binding of glycolytic enzymes to muscle cytoskeleton, prevented by calmodulin antagonists. Livnat T, Chen-Zion M, Beitner R. Biochem Med Metab Biol; 1994 Oct; 53(1):28-33. PubMed ID: 7857679 [Abstract] [Full Text] [Related]
9. Effects of long-term streptozotocin diabetes on cytoskeletal and cytosolic phosphofructokinase and the levels of glucose 1,6-bisphosphate and fructose 2,6-bisphosphate in different rat muscles. Chen-Zion M, Livnat T, Beitner R. Biochem Med Metab Biol; 1994 Dec; 53(2):137-44. PubMed ID: 7710770 [Abstract] [Full Text] [Related]
10. Insulin stimulates binding of phosphofructokinase to cytoskeleton and increases glucose 1,6-bisphosphate levels in NIH-3T3 fibroblasts, which is prevented by calmodulin antagonists. Ashkenazy-Shahar M, Ben-Porat H, Beitner R. Mol Genet Metab; 1998 Nov; 65(3):213-9. PubMed ID: 9851886 [Abstract] [Full Text] [Related]
12. Effects of carbamylcholine and pyridostigmine on cytoskeleton-bound and cytosolic phosphofructokinase and ATP levels in different rat tissues. Glass-Marmor L, Chen-Zion M, Beitner R. Gen Pharmacol; 1996 Oct; 27(7):1241-6. PubMed ID: 8981075 [Abstract] [Full Text] [Related]
15. Control of glycolytic enzymes through binding to cell structures and by glucose-1,6-bisphosphate under different conditions. The role of Ca2+ and calmodulin. Beitner R. Int J Biochem; 1993 Mar; 25(3):297-305. PubMed ID: 8462719 [No Abstract] [Full Text] [Related]
16. Trifluoperazine abolishes the actions of bradykinin on glucose 1,6-bisphosphate levels and on the activities of glucose 1,6-bisphosphatase, phosphofructokinase and phosphoglucomutase. Beitner R, Kaplansky M, Frucht H. Int J Biochem; 1985 Mar; 17(4):545-50. PubMed ID: 2989025 [Abstract] [Full Text] [Related]
17. Decrease in cytoskeleton-bound phosphofructokinase in muscle induced by high intracellular calcium, serotonin and phospholipase A2 in vivo. Lilling G, Beitner R. Int J Biochem; 1990 Mar; 22(8):857-63. PubMed ID: 2149116 [Abstract] [Full Text] [Related]